Instrument Fundamentals
Date | Close | Change | Change (%) | Open | High | Low |
---|
News

Bristol-Myers Squibb Co (BMY) Trading Down 4.11% on Apr 23

Is Bristol-Myers Squibb Company (BMY) the Best Stock That Will Always Grow?

Tower Research Capital LLC TRC Acquires 58,625 Shares of Bristol-Myers Squibb (NYSE:BMY)

IHT Wealth Management LLC Sells 26,622 Shares of Bristol-Myers Squibb (NYSE:BMY)

Aurobindo Pharma arm Eugia gets USFDA nod for Dasatinib tablets, eyes $1.8 billion market

Bristol Myers Squibb divulges new RIPK1 inhibitors | BioWorld

Bristol Myers (BMY) Shares Phase 3 Trial Results for Cobenfy in Schizophrenia | BMY Stock News

Bristol Myers Squibb Announces Topline Results from Phase 3 ARISE Trial Evaluating Cobenfy ...

Bristol Myers Squibb's Schizophrenia Treatment Falls Flat | Morningstar

Pope's Fatal Stroke; Intravascular Catheter Warning; Cardiologist-Romance Author | MedPage Today

Stifel Financial Corp Reduces Stock Position in Bristol-Myers Squibb (NYSE:BMY)

Bristol-Myers Squibb (NYSE:BMY) Shares Sold by Teachers Retirement System of The State of Kentucky

Piper Sandler Initiates Coverage on Bristol-Myers Squibb (NYSE:BMY)

Bristol Myers (BMY) Sees Neutral Rating with $55 Price Target by Cantor Fitzgerald | BMY Stock News

Bristol Myers (BMY) Rated Overweight by Piper Sandler Amid Reinvention Efforts | BMY Stock News

Norinchukin Bank The Boosts Position in Bristol-Myers Squibb (NYSE:BMY)

Bristol-Myers Squibb (NYSE:BMY) Shares Sold by Ossiam

BI Asset Management Fondsmaeglerselskab A S Purchases 163,121 Shares of Bristol-Myers Squibb (NYSE:BMY)

Shaping the future of inflammatory bowel disease: a global research agenda for better management and public health response

Paranasal Sinus Cancer Treatment Market Size in 7MM is expected to grow at a decent CAGR by 2032, estimates DelveInsight | ABNewswire

Bristol Myers' Camzyos Update Boosts Prospects for Cytokinetics (CYTK) | BMY Stock News

Natixis Sells 108,957 Shares of Bristol-Myers Squibb (NYSE:BMY)

Capital International Inc. CA Buys 18,178 Shares of Bristol-Myers Squibb (NYSE:BMY)

Commerce Bank Decreases Stock Position in Bristol-Myers Squibb (NYSE:BMY)

Age-related divergence of circulating immune responses in patients with solid tumors treated with immune checkpoint inhibitors

Short Interest in Bristol-Myers Squibb (NYSE:BMY) Drops By 20.6%

Capital Group Private Client Services Inc. Raises Stock Position in Bristol-Myers Squibb (NYSE:BMY)

Capital International Sarl Acquires 37,067 Shares of Bristol-Myers Squibb (NYSE:BMY)

Regal Investment Advisors LLC Cuts Stock Holdings in Bristol-Myers Squibb (NYSE:BMY)

Freedom Investment Management Inc. Raises Position in Bristol-Myers Squibb (NYSE:BMY)

Forum Financial Management LP Has $955,000 Stock Holdings in Bristol-Myers Squibb (NYSE:BMY)

Bristol-Myers Squibb (NYSE:BMY) Shares Sold by Canada Pension Plan Investment Board

Demars Financial Group LLC Acquires New Holdings in Bristol-Myers Squibb (NYSE:BMY)

Bristol-Myers Squibb (NYSE:BMY) Shares Sold by Gamco Investors INC. ET AL

Bristol-Myers Squibb (BMY) Shares Decline Amid FDA Updates and Mixed Trial Results

Bristol-Myers Squibb (NYSE:BMY) Position Boosted by NewEdge Advisors LLC

Cadence Bank Sells 2,241 Shares of Bristol-Myers Squibb (NYSE:BMY)

Capital International Investors Has $2.59 Billion Stake in Bristol-Myers Squibb (NYSE:BMY)

One Mind's Rising Star Awards Celebrates 20 Years of Funding Innovative Mental Health Research | Morningstar

First Commonwealth Financial Corp PA Makes New $227,000 Investment in Bristol-Myers Squibb (NYSE:BMY)

Bristol-Myers Squibb (NYSE:BMY) Stock Holdings Cut by Insigneo Advisory Services LLC

Bristol Myers (BMY) Gains FDA Nod for Updated Camzyos Label to Simplify Treatment | BMY Stock News

Bristol Myers says FDA updates Camzyos label to simplify treatment | Markets Insider

Stenger Family Office LLC Acquires Shares of 42,995 Bristol-Myers Squibb (NYSE:BMY)

NFJ Investment Group LLC Invests $12.56 Million in Bristol-Myers Squibb (NYSE:BMY)

United Capital Financial Advisors LLC Has $10.19 Million Stake in Bristol-Myers Squibb (NYSE:BMY)

Evotec SE (EVO) (Q4 2024) Earnings Call Highlights: Strong Q4 Performance and Strategic ...

Bristol-Myers Squibb Co (BMY) Announces FDA Updates for CAMZYOS Prescribing Information | BMY ...

U.S. Food and Drug Administration Updates CAMZYOS® (mavacamten)

U.S. Food and Drug Administration Updates Camzyos (mavacamten) Label to Reduce Echocardiography Monitoring Requirements and Contraindications

Demars Financial Group LLC Makes New $49.87 Million Investment in Bristol-Myers Squibb (NYSE:BMY)

MSH Capital Advisors LLC Invests $534,000 in Bristol-Myers Squibb (NYSE:BMY)

Bristol Myers (BMY) Target Price Trimmed as Revenue Projections Dip | BMY Stock News

Bridgewater Associates LP Boosts Stake in Bristol-Myers Squibb (NYSE:BMY)

M Holdings Securities Inc. Buys Shares of 12,202 Bristol-Myers Squibb (NYSE:BMY)

Mariner LLC Raises Holdings in Bristol-Myers Squibb (NYSE:BMY)

SageView Advisory Group LLC Buys 7,168 Shares of Bristol-Myers Squibb (NYSE:BMY)

Bristol Myers' heart disease drug fails to meet main goals in late-stage study
Is Bristol-Myers Squibb Company (BMY) The Dirt Cheap Stock To Invest In Now?

Chiron Investment Management LLC Purchases New Position in Bristol-Myers Squibb (NYSE:BMY)

Canada Post Corp Registered Pension Plan Acquires New Stake in Bristol-Myers Squibb (NYSE:BMY)

Belpointe Asset Management LLC Reduces Stock Position in Bristol-Myers Squibb (NYSE:BMY)

Bristol-Myers Squibb (NYSE:BMY) Shares Bought by Trustmark National Bank Trust Department

Bristol-Myers Squibb (NYSE:BMY) Shares Purchased by Summit Investment Advisors Inc.

Sagespring Wealth Partners LLC Acquires New Position in Bristol-Myers Squibb (NYSE:BMY)

Rockefeller Capital Management L.P. Decreases Position in Bristol-Myers Squibb (NYSE:BMY)

Bristol Myers Squibb (BMY) Partners with Optellum for AI Lung Cancer Diagnosis

Is Bristol-Myers Squibb Company (BMY) the Best Pharma Stock to Buy for Long Term Growth?

Cytokinetics (CYTK) Gains Favor as Key Trial by Bristol-Myers Falls Short | CYTK Stock News

BofA Adjusts Price Target for Cytokinetics (CYTK) Amid Competitive Developments | BMY Stock News

Optellum Announces Agreement with Bristol Myers Squibb to Leverage AI to Boost Early Lung ...

Bristol-Myers Squibb (NYSE:BMY) Shares Bought by Savvy Advisors Inc.

Bristol-Myers Squibb (NYSE:BMY) Position Trimmed by Synovus Financial Corp

Bristol-Myers Squibb (NYSE:BMY) Shares Purchased by Independent Franchise Partners LLP

Blackhill Capital Inc. Buys 8,700 Shares of Bristol-Myers Squibb (NYSE:BMY)

Ontario Teachers Pension Plan Board Acquires 13,394 Shares of Bristol-Myers Squibb (NYSE:BMY)

Advisors Capital Management LLC Boosts Stake in Bristol-Myers Squibb (NYSE:BMY)

Townsquare Capital LLC Has $12.86 Million Stock Holdings in Bristol-Myers Squibb (NYSE:BMY)

Failure to make findings of fact adds twist to battle over Eliquis in Ireland

Circulating tumour DNA and circulating tumour cells in bladder cancer - from discovery to clinical implementation

PD-1 Non-Small Cell Lung Cancer Therapeutics Market Size in 7MM is expected to grow at a decent CAGR by 2034, estimates DelveInsight | ABNewswire

Hearing Loss & Heart Failure; BP Drug Released From REMS; Fecal Transplants for PAH? | MedPage Today

Adjuvant BRAF/MEK versus anti-PD-1 in BRAF-mutant melanoma: a propensity score matched survival analysis

Bristol Myers Squibb (BMY) Sees Stock Dip as Camzyos Trial Falls Short

Bristol Myers' Heart Disease Drug Fails To Meet Primary Endpoints In Phase 3 Trial

Bristol Myers Squibb Provides Update on Phase 3 ODYSSEY-HCM Trial | BMY Stock News

Bristol Myers (BMY) Reports Unmet Goals in Key Trial for Camzyos | BMY Stock News

Bristol Myers says Phase 3 ODYSSEY-HCM Camzyos trial did not meet endpoints | Markets Insider
/cloudfront-us-east-1.images.arcpublishing.com/morningstar/HE2XT5SV5ZBU5MOM6PPYWRIGP4.png)
10 Best Blue-Chip Stocks to Buy for the Long Term | Morningstar

Petros Family Wealth LLC Acquires Shares of 9,555 Bristol-Myers Squibb (NYSE:BMY)

HDAC Inhibitors Market Projected to Grow Significantly Through 2034 | DelveInsight | ABNewswire

Bristol-Myers Squibb (NYSE:BMY) Price Target Cut to $54.00 by Analysts at UBS Group

Bristol-Myers Squibb (NYSE:BMY) Shares Bought by WealthTrust Axiom LLC

Scotia Capital Inc. Increases Stock Holdings in Bristol-Myers Squibb (NYSE:BMY)

Bristol-Myers Squibb (NYSE:BMY) Shares Sold by DRW Securities LLC

Zuckerman Investment Group LLC Lowers Stake in Bristol-Myers Squibb (NYSE:BMY)

Treasurer of the State of North Carolina Has $59.41 Million Stock Position in Bristol-Myers Squibb (NYSE:BMY)

LSV Asset Management Trims Position in Bristol-Myers Squibb (NYSE:BMY)
Latest news

Commodity market today: Crude Oil Fluctuates as OPEC+ Modifies Production Goals

Morning Note: Trump Calms Fed Fears; Tesla Disappoints; UK Trade Talks Begin

Stock Market Today: Dow, S&P 500, Nasdaq Fall as Trump Rips Fed Chair Powell

Morning Note: Trump's Fed Pressure Slams Stocks, Boosts Gold; Oil Recovers

Gold Price Today: XAU/USD Over $3,350 on Trump's Tariff Policies Uncertainty